Cingolani, L., Barberio, B., Zingone, F., Ferronato, A., Bertani, L., Costa, F., . . . Savarino, E. V. (2021). Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator. Nature Portfolio.
Chicago Style (17th ed.) CitationCingolani, Linda, et al. Adalimumab Biosimilars, ABP501 and SB5, Are Equally Effective and Safe as Adalimumab Originator. Nature Portfolio, 2021.
MLA (8th ed.) CitationCingolani, Linda, et al. Adalimumab Biosimilars, ABP501 and SB5, Are Equally Effective and Safe as Adalimumab Originator. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.